849PDPreliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC) S T Tagawa,J R Osborne, A Hackett,M J Niaz, V Cooley,P Christos,P J Vlachostergios,C Thomas, L Gracey,H Beltran,A M Molina,D M Nanus,J Babich,S Vallabhajosula,O Sartor,K Ballman,N H BanderANNALS OF ONCOLOGY（2019）引用 14|浏览38暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
